Capital Analysts, LLC Embecta Corp. Transaction History
Capital Analysts, LLC
- $2.49 Billion
- Q4 2024
A detailed history of Capital Analysts, LLC transactions in Embecta Corp. stock. As of the latest transaction made, Capital Analysts, LLC holds 1,753 shares of EMBC stock, worth $24,717. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,753
Previous 1,838
4.62%
Holding current value
$24,717
Previous $26,000
38.46%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding EMBC
# of Institutions
404Shares Held
52.4MCall Options Held
120KPut Options Held
66.8K-
Black Rock Inc. New York, NY9.19MShares$130 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.03MShares$99.1 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.27MShares$46.1 Million1.68% of portfolio
-
American Century Companies Inc Kansas City, MO3.26MShares$46 Million0.04% of portfolio
-
River Road Asset Management, LLC3.25MShares$45.8 Million0.95% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $815M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...